A high-performance liquid chromatography assay for quantification of cardiac myosin heavy chain isoform protein...

Area of Science:

• Biochemistry
• Cardiovascular Biology
• Analytical Chemistry

Background:

• Myocardial stress triggers a switch from adult α-myosin heavy chain (α-MyHC) to fetal β-myosin heavy chain (β-MyHC).
• This myosin isoform shift impairs cardiac contractility and myofibrillar ATPase activity, contributing to heart failure.
• Current methods for quantifying MyHC isoforms, like gel electrophoresis, are time-consuming and variable.

Purpose of the Study:

• To develop a rapid and reliable method for determining the relative expression of α-MyHC and β-MyHC in rat hearts.
• To facilitate drug discovery efforts targeting the myosin heavy chain (MyHC) axis in cardiovascular disease.

Main Methods:

• A reversed-phase high-performance liquid chromatography (HPLC) method was developed to quantify full-length α- and β-MyHC.
• The assay was validated using cardiac tissues from rats with pharmacologically manipulated thyroid hormone receptor activity.

Main Results:

• The developed HPLC method provides a facile and rapid determination of α-MyHC and β-MyHC isoform levels.
• The assay demonstrated efficacy in distinguishing changes in MyHC expression under varying transcriptional regulation.

Conclusions:

• This novel HPLC assay offers a significant improvement over traditional methods for MyHC isoform quantification.
• The assay is poised to accelerate drug discovery for heart failure by enabling efficient assessment of therapeutic interventions targeting the MyHC axis.